|
⚲
|
| Keyboard |
| Vida Ventures GP III LLC
✚
|
|
|---|---|
| CIK # | 0001855502 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001855502] | |
| 4 | [0001855502] | |
| SC 13D | [0001855502] |
| Form 13D/13G Filer | Form 13D/13G Subject | Filed |
|---|---|---|
| Vida Ventures GP III LLC | Vigil Neuroscience Inc | [2023-02-10] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Vida Ventures III-A LP | |
| Kyverna Therapeutics Inc | |
| Vida Ventures GP III LLC | |
| Vida Ventures III LP | |
| Vida Ventures LLC | |
| Vigil Neuroscience Inc |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Kyverna Therapeutics Inc KYTX
Series A-1 Redeemable Convertible Preferred Stock · derivative
|
2024-02-12 | Conversion | 4,401,771 | $0.00 | |
|
Kyverna Therapeutics Inc KYTX
Common Stock
|
2024-02-12 | Conversion | 4,523,924 | ||
|
Kyverna Therapeutics Inc KYTX
Common Stock
|
2024-02-12 | Buy | 252,553 | $22.00 | 5,556,166 |
|
Kyverna Therapeutics Inc KYTX
Common Stock
|
2024-02-12 | Buy | 583 | $22.00 | 12,826 |
|
Kyverna Therapeutics Inc KYTX
Series B Redeemable Convertible Preferred Stock · derivative
|
2024-02-12 | Conversion | 7,356,162 | $0.00 | |
|
Kyverna Therapeutics Inc KYTX
Series A-2 Redeemable Convertible Preferred Stock · derivative
|
2024-02-12 | Conversion | 8,830,901 | $0.00 | |
|
Vigil Neuroscience Inc VIGL
Common Stock
|
2022-01-11 | Conversion | 7,684 | ||
|
Vigil Neuroscience Inc VIGL
Common Stock
|
2022-01-11 | Buy | 3,852 | $14.00 | 53,928 |
|
Vigil Neuroscience Inc VIGL
Common Stock
|
2022-01-11 | Conversion | 3,333,245 | ||
|
Vigil Neuroscience Inc VIGL
Common Stock
|
2022-01-11 | Buy | 1,671,148 | $14.00 | 23,396,072 |
|
Vigil Neuroscience Inc VIGL
Series B Preferred Stock · derivative
|
2022-01-11 | Conversion | 9,243,756 | $0.00 | |
|
Vigil Neuroscience Inc VIGL
Series B Preferred Stock · derivative
|
2022-01-11 | Conversion | 21,310 | $0.00 |